Ceres Inc  

(Public, NASDAQ:CERE)   Watch this stock  
Find more results for CERE
+0.015 (1.63%)
Nov 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.92 - 0.94
52 week 0.90 - 4.80
Open 0.94
Vol / Avg. 0.00/192,876.00
Mkt cap 8.26M
P/E     -
Div/yield     -
EPS -4.55
Shares 8.83M
Beta 0.86
Inst. own 30%
Jan 11, 2016
Q1 2016 Ceres Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Nov 23, 2015
Q4 2015 Ceres Inc Earnings Call
Nov 23, 2015
Q4 2015 Ceres Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Aug '15) 2015
Net profit margin -959.39% -1035.15%
Operating margin -961.38% -1035.92%
EBITD margin - -1011.76%
Return on average assets -267.28% -129.32%
Return on average equity -482.82% -176.96%
Employees 44 -
CDP Score - -


1535 Rancho Conejo Blvd
THOUSAND OAKS, CA 91320-1440
United States - Map
+1-805-3766500 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Ceres, Inc. (Ceres) is an agricultural biotechnology company that develops and markets seeds to produce crops for bioenergy and other markets that utilize plant biomass. It uses a combination of advanced plant breeding, biotechnology and bioinformatics to develop seed products. One of commercial opportunities is in Brazil where the Company is pursuing multiple markets for its sorghum products. It markets its sweet sorghum hybrids as a drop-in feedstock to complement existing feedstock supplies and extend the operating season of Brazilian sugarcane-to-ethanol mills. It also markets its high biomass sorghum products to mills and other agri-industrial facilities for use in generating electricity, heat and steam. It markets and sells its seed products under its Blade brand. It generates revenues from government grants, research and development collaboration agreements and from product sales. The Company’s products include sorghum, switchgrass and miscanthus.

Officers and directors

Richard William Hamilton Ph.D. President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Paul M. Kuc Chief Financial Officer
Age: 52
Bio & Compensation  - Reuters
Wilfriede van Assche Senior Vice President, General Counsel and Secretary
Age: 60
Bio & Compensation  - Reuters
Roger Pennell Ph.D. Vice President - Trait Development
Age: 55
Bio & Compensation  - Reuters
Cheryl P. Morley Chairman of the Board
Age: 60
Bio & Compensation  - Reuters
Richard Bailey Flavell Ph.D., FRS, CBE Director
Age: 71
Bio & Compensation  - Reuters
Aflalo Guimaraes Director
Age: 46
Bio & Compensation  - Reuters
Pascal Brandys Independent Director
Age: 56
Bio & Compensation  - Reuters
Robert Bruce Goldberg Ph.D. Independent Director
Age: 70
Bio & Compensation  - Reuters
Thomas D. Kiley Esq. Independent Director
Age: 71
Bio & Compensation  - Reuters